Evropská unie - chorvatština - EMA (European Medicines Agency)

accord healthcare s.l.u. - abirateron acetat - prostatske neoplazme - endokrinska terapija - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Evropská unie - chorvatština - EMA (European Medicines Agency)

gedeon richter plc. - relugolix, norethisterone acetate, estradiol hemihydrate - uterusa - hipofiza i hipotalamusni hormoni i analozi - ryeqo is indicated in adult women of reproductive age for:- treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.

Evropská unie - chorvatština - EMA (European Medicines Agency)

krka, d.d., novo mesto - abirateron acetat - prostatske neoplazme - endokrinska terapija - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Evropská unie - chorvatština - EMA (European Medicines Agency)

pfizer europe ma eeig - somatrogon - growth and development - hipofize i ГИПОТАЛАМИЧЕСКИЕ hormoni i analozi - indicated for the long-term treatment of paediatric patients with growth disturbance due to insufficient secretion of growth hormone.

Evropská unie - chorvatština - EMA (European Medicines Agency)

accord healthcare s.l.u. - leuprorelin mesilate - prostatske neoplazme - endokrinska terapija - camcevi is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.

Bosna a Hercegovina - chorvatština - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

farmal bh d.o.o. - etinilestradiol, levonorgestrel - filmom obložena tableta - 0.03 mg/1 tableta+ 0.15 mg/1 tableta - 1 filmom obložena tableta sadrži: 0,03 mg etinilestradiola 0,15 mg levonorgestrela

Chorvatsko - chorvatština - HALMED (Agencija za lijekove i medicinske proizvode)

merck d.o.o., oreškovićeva ulica 6h/1, zagreb, hrvatska - levotiroksinnatrij - tableta - 100 mikrograma - urbroj: jedna tableta sadrži 100 mikrograma levotiroksinnatrija

Chorvatsko - chorvatština - HALMED (Agencija za lijekove i medicinske proizvode)

merck d.o.o., oreškovićeva ulica 6h/1, zagreb, hrvatska - levotiroksinnatrij - tableta - 112 mikrograma - urbroj: jedna tableta sadrži 112 mikrograma levotiroksinnatrija

Chorvatsko - chorvatština - HALMED (Agencija za lijekove i medicinske proizvode)

merck d.o.o., oreškovićeva ulica 6h/1, zagreb, hrvatska - levotiroksinnatrij - tableta - 125 mikrograma - urbroj: jedna tableta sadrži 125 mikrograma levotiroksinnatrija

Chorvatsko - chorvatština - HALMED (Agencija za lijekove i medicinske proizvode)

merck d.o.o., oreškovićeva ulica 6h/1, zagreb, hrvatska - levotiroksinnatrij - tableta - 150 mikrograma - urbroj: jedna tableta sadrži 150 mikrograma levotiroksinnatrija